Françoise Pierard

The discovery of the potent aurora inhibitor MK-0457 (VX-680).

David Bebbington, Michael O'Donnell, Damien Fraysse, 2009, Bioorganic & medicinal chemistry letters.

Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis.

L. Settimo, A. Tanner, H. Twin, 2019, ACS medicinal chemistry letters.

Design and optimization of selective protein kinase C θ (PKCθ) inhibitors for the treatment of autoimmune diseases.

L. Settimo, A. Tanner, Jaclyn L Henderson, 2013, Journal of medicinal chemistry.

Catalytic enantioselective rearrangements and cycloadditions involving ylides from diazo compounds

D. M. Hodgson, F. Pierard, P. Stupple, 2001 .

Development of dirhodium(II)-catalyzed generation and enantioselective 1,3-dipolar cycloaddition of carbonyl ylides.

C. Johnstone, D. M. Hodgson, A. Labande, 2001, Chemistry.

The scope of catalytic enantioselective tandem carbonyl ylide formation-intramolecular [3 + 2] cycloadditions.

D. M. Hodgson, A. Labande, F. Pierard, 2003, The Journal of organic chemistry.

The discovery of the potent aurora inhibitor MK-0457 (VX-680).

M. Mortimore, D. Kay, D. Bebbington, 2009, Bioorganic & medicinal chemistry letters.